Six-month intervention with wild blueberries improved speed of processing in mild cognitive decline: a double-blind, placebo-controlled, randomized clinical trial

被引:13
|
作者
Cheatham, Carol L. [1 ,2 ]
Canipelll, L. Grant [1 ,3 ]
Millsap, Grace [2 ]
Stegall, Julie M. [2 ]
Chai, Sheau Ching [2 ,4 ]
Sheppard, Kelly W. [1 ]
Lila, Mary Ann [5 ,6 ]
机构
[1] Univ N Carolina, Dept Psychol & Neurosci, Chapel Hill, NC 27515 USA
[2] Univ North Carolina Chapel Hill, Nutr Res Inst, Kannapolis, NC 28081 USA
[3] Chicago Sch Profess Psychol, Fac Clin Psychol, Dallas, TX USA
[4] Univ Delaware, Fac Behav Hlth & Nutr, Newark, DE USA
[5] North Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC USA
[6] North Carolina State Univ, Plants Human Hlth Inst, Kannapolis, NC USA
关键词
aging; CANTAB; event-related potentials; flavonoids; mild cognitive decline; speed of processing; polyphenols; wild blueberries; COCOA FLAVANOL CONSUMPTION; OLDER-ADULTS; MEDITERRANEAN DIET; ELDERLY SUBJECTS; BLOOD-PRESSURE; SUPPLEMENTATION; DEMENTIA; DYSFUNCTION; BEHAVIOR; MEMORY;
D O I
10.1080/1028415X.2022.2117475
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: As the sector of the population over 65y increases, cognitive decline and dementia become a public health issue. Interventions to improve brain health and thus, quality of life for older adults are needed. Objective: It was hypothesized that those consuming a flavonoid-rich, lyophilized wild blueberry powder would evidence improvements in cognitive performance as measured behaviorally and electrophysiologically compared to those consuming a placebo powder across a 6-month intervention period. Design: In a double-blind, randomized placebo-controlled trial, participants experiencing cognitive issues as determined by scores on the Montreal Cognitive Assessment (MoCA) were randomized to consume either wild blueberry (n = 44) or placebo (n = 42) powder daily for 6 months. Participants who were not experiencing any cognitive issues were included as a reference group (n = 45). Participants were tested at baseline and outcome on the Cambridge Neurological Test Automated Battery (CANTAB) and in an electrophysiological paradigm known as event-related potentials (ERP). Results: Tests of specific cognitive abilities using the CANTAB showed speed of processing not only improved in the blueberry intervention group relative to the placebo group across the 6-month intervention, but blueberries also restored speed of processing to the level of the reference group. The ERP results also showed that, relative to those consuming placebo, speed of processing improved for those in the blueberry group; this improvement was most prominent in those 75-80y. Conclusions: Consumption of wild blueberries for six months improves cognitive aging sequelae by improving the speed of information processing in older adults.
引用
收藏
页码:1019 / 1033
页数:15
相关论文
共 50 条
  • [31] Melatonin in Assisted Reproductive Technology: A Pilot Double-Blind Randomized Placebo-Controlled Clinical Trial
    Fernando, Shavi
    Wallace, Euan Morrison
    Vollenhoven, Beverley
    Lolatgis, Nicholas
    Hope, Nicole
    Wong, Melissa
    Lawrence, Mark
    Lawrence, Anthony
    Russell, Chris
    Leong, Kenneth
    Thomas, Philip
    Rombauts, Luk
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [32] Therapeutic effect of Achillea millefolium on the hemorrhoids; A randomized double-blind placebo-controlled clinical trial
    Mahmoudi, Aynaz
    Seyedsadeghi, Mirsalim
    Miran, Mansour
    Ahari, Saeid Sadeghieh
    Layegh, Hojat
    Mostafalou, Sara
    JOURNAL OF HERBAL MEDICINE, 2023, 39
  • [33] Clinical Benefits of Antioxidative Supplement Twendee X for Mild Cognitive Impairment: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Prospective Interventional Study
    Tadokoro, Koh
    Morihara, Ryuta
    Ohta, Yasuyuki
    Hishikawa, Nozomi
    Kawano, Satoko
    Sasaki, Ryo
    Matsumoto, Namiko
    Nomura, Emi
    Nakano, Yumiko
    Takahashi, Yoshiaki
    Takemoto, Mami
    Yamashita, Toru
    Ueno, Setsuko
    Wakutani, Yosuke
    Takao, Yoshiki
    Morimoto, Nobutoshi
    Kutoku, Yumiko
    Sunada, Yoshihide
    Taomoto, Katsushi
    Manabe, Yasuhiro
    Deguchi, Kentaro
    Higashi, Yasuto
    Inufusa, Haruhiko
    You, Fukka
    Yoshikawa, Toshikazu
    von Greiffenclau, Markus Matuschka
    Abe, Koji
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 71 (03) : 1063 - 1069
  • [34] Supplemental Retinal Carotenoids Enhance Memory in Healthy Individuals with Low Levels of Macular Pigment in A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Power, Rebecca
    Coen, Robert F.
    Beatty, Stephen
    Mulcahy, Riona
    Moran, Rachel
    Stack, Jim
    Howard, Alan N.
    Nolan, John M.
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 61 (03) : 947 - 961
  • [35] Effects of Composite Supplement Containing Astaxanthin and Sesamin on Cognitive Functions in People with Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial
    Ito, Naoki
    Saito, Hitomi
    Seki, Shinobu
    Ueda, Fumitaka
    Asada, Takashi
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 62 (04) : 1767 - 1775
  • [36] A Randomized, Double-blind, Placebo-Controlled Study of Latrepirdine in Patients With Mild to Moderate Huntington Disease
    Kieburtz, Karl
    Landwehrmeyer, Georg B.
    Cudkowicz, Merit
    Dorsey, E. Ray
    Feigin, Andrew
    Hunt, Victoria
    Kayson, Elise
    McDermott, Michael
    Noonberg, Sarah
    Seitz, Wendy
    Soliveri, Paola
    Walker, Francis
    Burgunder, Jean-Marc
    Romero, Irene
    Magara, Anouk
    Stebler, Yanik
    Rickards, Hugh
    Wright, Jan
    De Souza, Jenny
    Barker, Roger A.
    Mason, Sarah
    Di Pietro, Anna
    Goodman, Anna
    O'Keeffe, Deidre
    Langlois, Melanie
    Ferland, Germain
    Verret, Louis
    Chouinard, Sylvain
    Paris, Suzanne
    LePage, Christiane
    Nemeth, Andrea H.
    Merritt, Claire
    Cox, Caroline
    Astbury, Therese
    Murphy, Sarah
    Ahmed, Anwar
    St Marie, Patricia
    Berila, Rose Anne
    Kubu, Cynthia
    Segro, Vicki
    Kumar, Rajeev
    Erickson, Diane
    Schneiders, Jay
    Frucht, Steven
    Wasserman, Paula
    Moskowitz, Carol
    Scott, Burton
    Perry-Trice, Peggy
    Wyne, Sarah
    Soliveri, Paola
    JAMA NEUROLOGY, 2013, 70 (01) : 25 - 33
  • [37] Oral Magnesium Supplementation and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial
    Rodriguez-Moran, Martha
    Simental-Mendia, Luis E.
    Gamboa-Gomez, Claudia, I
    Guerrero-Romero, Fernando
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2018, 25 (03) : 261 - 266
  • [38] Tolerability of glutamine supplementation in older adults: a double-blind placebo-controlled randomized clinical trial
    de Nobrega, T. C. M.
    da Silva, M. A. R. C. P.
    Rampani, E. M.
    Curi, R.
    Bazotte, R. B.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2024, 57
  • [39] Plasma ubiquinone status and response to six-month supplementation combined with multivitamins in healthy elderly women - Results of a randomized, double-blind, placebo-controlled study
    Wolters, M
    Hahn, A
    INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH, 2003, 73 (03) : 207 - 214
  • [40] Randomized, double-blind, placebo-controlled international clinical trial of the AMPAKINE® CX516 in elderly participants with mild cognitive impairment -: A progress report
    Johnson, SA
    Simmon, VF
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2002, 19 (1-2) : 197 - 200